Docosahexaenoic acid (DHA) and cardiovascular disease risk factors

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 2-3, 2009, Pages 199-204

  Holub, Bruce J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; PHOSPHOLIPID BLOOD LEVEL; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; SUDDEN DEATH; TRIACYLGLYCEROL BLOOD LEVEL;

CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EUKARYOTA; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; NUTRITION POLICY; RISK FACTORS; TRIGLYCERIDES;

ALGAE;

EID: 69449095966     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.05.016     Document Type: Article

References (50)

1. Holub D.J., and Holub B.J. Omega-3 fatty acids from fish oils and cardiovascular disease. Mol. Cell Biochem. 263 1-2 (2004) 217-225
2. Harris W.S., Miller M., Tighe A.P., Davidson M.H., and Schaefer E.J. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic prospectives. Atherosclerosis 197 1 (2008) 12-24
3. E.M. Balk, A.H. Lichtenstein, M. Chung, B. Kupelnick, P. Chew, J. Lau, Effect of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review, Atherosclerosis 189 (1) (2006) 19-30.
4. Holub B.J. Clinical nutrition 4: omega-3 fatty acids in cardiovascular care. CMAJ 166 5 (2002) 608-615
5. Iso H., Sato S., Folsom A.R., et al. Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. Int. J. Epidemiol. 18 2 (1989) 374-381
6. Daviglus M.L., Stamler J., Orencia A.J., et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N. Eng. J. Med. 336 (1997) 1046-1053
7. Raper N.R., Cronin F.J., and Exler J. Omega-3 fatty acid content of the US food supply. J. Am. Coll. Nutr. 11 3 (1992) 304-308
8. Denomme J., Stark K., and Holub B.J. Directly quantitated dietary (n-3) fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations. J. Nutr. 135 (2005) 206-211
9. Dolecek T.A. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. Proc. Soc. Exp. Biol. Med. (1992) 177-182
10. He K., Song Y., Davilgus M.l., Liu, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109 22 (2004) 2705-2711
11. Simopoulos A.P., Leaf A., and Salem N. Workshop on the essentiality of and recommended intakes for omega-6 and omega-3 fatty acids. J. Am. Coll. Nutr. 18 5 (1999) 487-489
12. Marchioli R. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
13. Jacobson T.A. Beyond lipids: the role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease. Curr. Atheroscler. Rep. 9 2 (2007) 145-153
14. Gotto A.M. Triglyceride: the forgotten risk factor. Circulation 97 11 (1998) 1027-1028
15. Cullen P. Evidence the triglycerides are an independent coronary heart disease risk factor. Am. J. Cardiol. 86 (2000) 943-949
16. Onat A., Sari I., Yazici M., Can G., Hergenc G., and Avci G.S. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome. Int. J. Cardiol. 108 1 (2006) 89-95
17. Gaziano J.M., Hennekens C.M., O'Donnell C.J., Breslow J.L., and Buring J.E. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96 8 (1997) 2520-2525
18. Szapary P.O., and Rader D.J. The triglyceride-high-density lipoprotein axis: an important target of therapy?. Am. Heart J. 148 2 (2004) 211-221
19. Maruyama C., Imamura K., and Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J. Atheroscler. Thromb. 10 3 (2003) 186-191
20. Farwell W.R., Sesso H.D., Buring J.E., and Gaziano J.M. Non-high density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction. Am. J. Cardiol. 96 8 (2005) 1129-1134
21. Harris W.S. n-3 Fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65 s (1997) 1645s-1654s
22. Grimsgaard S., Bonaa K.H., Hansen J.B., and Nordoy A. Highly purified eicosapentaenoic acid and docosapentaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am. J. Clin. Nutr. 66 3 (1997) 649-659
23. Schwellenbach L.J., Olson K.L., McConnell K.J., Stolcpart R.S., Nash J.D., and Merenich J.A. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. J. Am. Coll. Nutr. 25 6 (2006) 480-485
24. Conquer J.A., and Holub B.J. Supplementation with and algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J. Nutr. 126 12 (1996) 3032-3039
25. Conquer J.A., and Holub B.J. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 32 3 (1997) 341-345
26. Arterburn L.M., Oken H.A., Hoffman J.P., et al. Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in DHA fortified food. Lipids 42 11 (2007) 1011-1024
27. Nelson G.J., Schmidt P.S., Bartolini G.L., Kelley D.S., and Kyle D.J. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 32 11 (1997) 1129-1137
28. Theobald H.E., Chowienczyk P.J., Whittall R., Humphries S.E., and Sanders T.A. LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women. Am. J. Clin. Nutr. 79 4 (2004) 558-563
29. Stark K.D., and Holub B.J. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am. J. Clin. Nutr. 78 5 (2004) 765-773
30. Maki K.C., Van Elswyk M.E., McCarthy D., et al. Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol. J. Am. Coll. Nutr. 24 3 (2005) 189-199
31. Geppert J., Kraft V., Demmelmair H., and Koletzko B. Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial. Br. J. Nutr. 95 4 (2006) 779-786
32. Kelley D.S., Siegel D., Vemuri M., and Mackey B.E. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am. J. Clin. Nutr. 86 2 (2007) 324-333
33. Conquer J.A., and Holub B.J. Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J. Lipid Res. 39 2 (1998) 286-292
34. Karpe F., de Faire U., Mercuri M., Bond M.G., Hellénius M.L., and Hamsten A. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. Atherosclerosis 141 2 (1998) 307-314
35. Agren J.J., Hänninen O., Julkunen A., Fogelholm L., et al. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. Eur. J. Clin. Nutr. 50 11 (1996) 765-771
36. Girerd X., and Giral P. Risk stratification for the prevention of cardiovascular complications of hypertension. Curr. Med. Res. Opin. 20 7 (2004) 1137-1142
37. Palatini P. Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms. Drugs 67 Suppl 2 (2007) 3-13
38. Mori T.A., Bao D.Q., Burque V., Puddey I.B., and Beilin L.J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34 2 (1999) 253-260
39. Kang J.X., and Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids. Recent studies. Circulation 94 7 (1996) 1774-1880
40. Pepe S., and McLennan P.L. Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats. J. Nutr. 126 1 (1996) 34-42
41. Nair S.S., Leitch J.W., Falconer J., and Garg M.L. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J. Nutr. 127 3 (1997) 383-393
42. Theobald H.E., Goodall A.H., Sattar N., Talbot D.C., and Cowienczyk. Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J. Nutr. 137 4 (2007) 973-978
43. Kelley D.S., Siegel D., Fedor D.M., Adkins Y., and Mackey B.E. DHA supplementation decreases serum c-reactive protein and other markers of inflammation in hypertriglyceridemic men. J. Nutr. 139 (2009) 495-501
44. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willett W.C., and Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346 15 (2002) 1113-1118
45. Simon J.A., Hodgkins M.L., Browner W.S., Neuhaus J.M., Bernert Jr. J.T., and Hulley S.B. Serum fatty acids and the risk of coronary heart disease. Am. J. Epidemiol. 142 5 (1995) 469-476
46. Erkkilä A.T., Matthan N.R., Herrington D.M., and Lichtenstein A.H. Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD. J. Lipid Res. 47 12 (2006) 2814-2819
47. Kris-Etherton P.M., Harris W.S., and Appel L.J. AHA Scientific Statement: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
48. Position of the American Dietetic Association and Dietitians of Canada: Dietary Fatty Acids. J. Am. Diet. Assoc. 107 (2007) 1599-1611.
49. Kris-Etherton P.M., and Hill A.M. n-3 Fatty acids: food or supplements. J. Am. Diet. Assoc. 108 7 (2008) 1125-1130
50. Harris W.S., Mozaffarian D., Lefevre M., Toner C.D., Colombo J., Cunnane S.C., Holden J.M., Klurfeld D.M., Morris M.C., and Whelan J. Towards establishing dietary reference intakes for eicosapentaenoic acid and docosahexaenoic acids. J. Nutr. 139 (2009) 804S-819S